文献速递生殖医学

ADCY10移码变异导致严重隐性弱精子症并与吸收性高钙尿症共分离

ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria.
PubMed 文献 · Hum Reprod · 2019-01-01

本研究对一个近亲婚配的伊朗弱精子症家系进行全外显子测序,发现两名患者为ADCY10编码区罕见2bp缺失(c.1205_1206del, rs779944215)的纯合子,该变异导致提前终止(p.His402Argfs*41)。患者精子经细胞通透性cAMP类似物处理后活力显著增加,提示该变异致病;同一变异还以显性遗传方式与家系内吸收性高钙尿症共分离。

要点

  • ADCY10纯合移码变异c.1205_1206del(rs779944215)导致严重隐性弱精子症。
  • 患者精子经cAMP类似物处理后活力显著增加,支持该变异致病。
  • 同一变异以显性遗传方式与吸收性高钙尿症共分离。

核心结论

  • ADCY10纯合移码变异c.1205_1206del(rs779944215)导致严重隐性弱精子症,并同一变异以显性遗传方式与吸收性高钙尿症共分离。

研究设计与样本

  • 2016年在伊朗招募一个近亲婚配的弱精子症家系,进行回顾性遗传学研究。
  • 对两名弱精子症患者、各自父母及一名未患病兄弟进行全外显子测序,变异经Sanger测序验证并与表型共分离。
  • 为确认致病性,将两名患者、10名正常精子症男性和10名不携带该变异的弱精子症患者的精液样本用人输卵管液培养基溶解的cAMP类似物处理,随后进行计算机辅助精液分析和统计分析。

主要发现

  • 发现的纯合变异位于ADCY10核苷酸结合位点上游10个氨基酸处,导致提前终止(p.His402Argfs*41)。
  • 患者精子样本经细胞通透性cAMP类似物处理后精子活力显著增加,表明该变异具有致病作用。
  • 家系内共分离的吸收性高钙尿症也与同一变异相关,呈显性遗传。

局限性

  • 尽管突变转录本极可能发生无义介导的衰变,但由于成熟精子中RNA水平低,作者未能证实这一点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can whole exome sequencing (WES) reveal a novel pathogenic variant in asthenozoospermia in a multiplex family including multiple patients? SUMMARY ANSWER: Patients were discovered to be homozygous for a rare 2-bp deletion in the ADCY10 coding region (c.1205_1206del, rs779944215). WHAT IS KNOWN ALREADY: ADCY10 encodes for soluble adenylyl cyclase (sAC), which is the predominant adenylate cyclase in sperm. It is already established that proper sAC activity and a constant supply of cAMP are crucial to sperm motility regulation, and knockout mouse models have been reported as severely asthenozoospermic. ADCY10 is a susceptibility gene for dominant absorptive hypercalciuria (OMIM#143870); however, no ADCY10 variations have been confirmed to cause human asthenozoospermia to date. STUDY DESIGN, SIZE, DURATION: This was a retrospective genetics study of a highly consanguineous pedigree of asthenozoospermia. The subject family was recruited in Iran in 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: The two patients were diagnosed as asthenozoospermic through careful clinical investigations. Both patients, respective parents, and an unaffected brother were subjected to WES. The discovered variant was validated by Sanger sequencing and segregated with the phenotype. To confirm the pathogenicity of the variant, sperm samples from both patients, 10 normozoospermic men and 10 asthenozoospermic patients not representing the variation, were treated with a cAMP analogue dissolved in human tubal fluid medium, followed by computer-assisted sperm analysis and statistical analyses. MAIN RESULTS AND THE ROLE OF CHANCE: The discovered homozygous variant occurs at 10 amino acids upstream of the ADCY10 nucleotide binding site leading to a premature termination (p.His402Argfs*41). Treatment of the patients' sperm samples with a cell-permeable cAMP analogue resulted in a significant increase in sperm motility, indicating the pathogenic role of the variant. Moreover, absorptive hypercalciuria, segregating within the family, was also associated with the same variant following a dominant inheritance. LIMITATIONS, REASONS FOR CAUTION: Though nonsense-mediated decay is highly likely to occur in the mutated transcripts, we were not able to confirm this due to low RNA levels in mature sperm. WIDER IMPLICATIONS OF THE FINDINGS: Our finding enlarges the phenotypic spectrum associated with the ADCY10 gene, previously described as a susceptibility gene for dominant absorptive hypercalciuria. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the Royan Institute, Tehran, Iran, and San Raffaele Hospital, Milan, Italy. The authors have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Akbari A, Pipitone GB, Anvar Z, et al. ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria. Hum Reprod. 2019. PMID: 31119281. doi:10.1093/humrep/dez048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。